Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tactile Systems Technology ( (TCMD) ) has provided an announcement.
On February 17, 2026, Tactile Medical reported that fourth-quarter 2025 revenue rose 21% year over year to $103.6 million, with gross margin improving to 78% and net income reaching $10.6 million as both lymphedema and airway clearance product lines drove growth. For full-year 2025, revenue increased 12% to $329.5 million, net income improved to $19.1 million and adjusted EBITDA climbed to $44.8 million, highlighting operational leverage.
The company strengthened its balance sheet by repaying the remaining $26.3 million term loan, ending 2025 debt-free with $83.4 million in cash, while returning $26.5 million to shareholders through stock repurchases. Strategically, Tactile Medical acquired LymphaTech to expand its lymphedema portfolio and digital 3D scanning capabilities, reported new clinical data on Flexitouch Plus, and issued a 2026 outlook calling for continued revenue and adjusted EBITDA growth, underscoring confidence in its market position and commercial momentum.
The most recent analyst rating on (TCMD) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Tactile Systems Technology stock, see the TCMD Stock Forecast page.
Spark’s Take on TCMD Stock
According to Spark, TipRanks’ AI Analyst, TCMD is a Outperform.
Tactile Systems Technology’s strong earnings call and positive corporate events, including a share buyback program, significantly boost its stock score. The technical analysis indicates strong upward momentum, although the stock may be overbought. Financial performance is solid but shows room for improvement in operational efficiency and cash flow growth. The valuation is relatively high, which slightly tempers the overall score.
To see Spark’s full report on TCMD stock, click here.
More about Tactile Systems Technology
Tactile Systems Technology, Inc., which does business as Tactile Medical, is a medical technology company focused on at-home therapies for underserved chronic conditions such as lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease. The company works with clinicians to build clinical evidence, improve access and lower healthcare costs while enhancing quality of life for tens of thousands of patients each year.
Average Trading Volume: 341,192
Technical Sentiment Signal: Buy
Current Market Cap: $590.8M
See more data about TCMD stock on TipRanks’ Stock Analysis page.